Sciex (Framingham, Massachusetts) and the Protein and Proteomics Center (PPC) under the Department of Biological Sciences of the National University of Singapore’s (NUS) Faculty of Sciences have signed a Memorandum of Understanding (MOU) to promote joint research and development activities in oncology biomarker discovery and development. The collaboration will pave the way for accelerated cancer detection and screening.
The PPC is a multi-user facility focusing on advanced research in proteins with an emphasis on mass spectrometry. Areas of expertise include biomarker discovery, proteomics, quantitative proteomics, and structural mass spectrometry (Amide hydrogen/deuterium exchange MS and ion mobility MS).
Under the partnership, Sciex and PPC’s areas of cooperation will include facilitating workshops on qualitative and quantitative proteomics to educate the regional research community on alternative methods for proteomics. Sciex and PPC researchers will also collaborate to develop mass spectrometry approaches for protein and metabolite profiling of zebrafish serum. The zebrafish is widely used as a model organism for biomedical research because of the similarity of its genetic makeup with that of humans. In particular, various zebrafish cancer models have been developed to facilitate cancer research.
Subsequent approaches and technologies developed by researchers will be applied to discover biomarkers of cancer progression, study the mechanisms and pharmacokinetics/pharmacodynamics of anti-cancer research, and uncover biomarkers for environmental monitoring.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.